Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
BMJ Open
|
June 14, 2020
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study
Thomas J Moore, James Heyward, Gerard Anderson, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 27, 2026
Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issues
Jeromie Ballreich, Joseph Levy, Tucker Desmond, et al.
Health Affairs Scholar
|
September 2, 2025
Research and development financing models for new biopharmaceuticals in the United States
So-Yeon Kang, Branden Lee, Ravi Gupta, et al.
Health Affairs Scholar
|
October 16, 2024
Biopharmaceutical pipeline funded by venture capital firms, 2014 to 2024
So-Yeon Kang, Mingqian Liu, Jeromie Ballreich, et al.
Medical Care Research and Review : MCRR
|
August 18, 2023
Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data
Yang Wang, Mark K Meiselbach, Jianhui Xu, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 24, 2021
Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs
Jeromie Ballreich, Ijeamaka Ezebilo, Banda Abdallah Khalifa, et al.
The Journal of Ambulatory Care Management
|
August 27, 2019
The Common Attributes of Successful Care Manager Programs for High-Need, High-Cost Persons: A Cross-Case Analysis
Emilia G Thurber, Cynthia Boyd, Bruce Leff, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 28, 2023
Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019
Angela Liu, Andrew Xuan, Mariana Socal, et al.
JAMA Ophthalmology
|
July 28, 2022
Association Between Open Payments-Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
Andrew M Nguyen, Kelly E Anderson, Gerard Anderson, et al.
Journal of Pharmaceutical Policy and Practice
|
October 14, 2017
Branded prescription drug spending: a framework to evaluate policy options
Jeromie Ballreich, G Caleb Alexander, Mariana Socal, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
BMJ Open
|
June 14, 2020
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study
Thomas J Moore, James Heyward, Gerard Anderson, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 27, 2026
Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issues
Jeromie Ballreich, Joseph Levy, Tucker Desmond, et al.
Health Affairs Scholar
|
September 2, 2025
Research and development financing models for new biopharmaceuticals in the United States
So-Yeon Kang, Branden Lee, Ravi Gupta, et al.
Health Affairs Scholar
|
October 16, 2024
Biopharmaceutical pipeline funded by venture capital firms, 2014 to 2024
So-Yeon Kang, Mingqian Liu, Jeromie Ballreich, et al.
Medical Care Research and Review : MCRR
|
August 18, 2023
Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data
Yang Wang, Mark K Meiselbach, Jianhui Xu, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 24, 2021
Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs
Jeromie Ballreich, Ijeamaka Ezebilo, Banda Abdallah Khalifa, et al.
The Journal of Ambulatory Care Management
|
August 27, 2019
The Common Attributes of Successful Care Manager Programs for High-Need, High-Cost Persons: A Cross-Case Analysis
Emilia G Thurber, Cynthia Boyd, Bruce Leff, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 28, 2023
Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019
Angela Liu, Andrew Xuan, Mariana Socal, et al.
JAMA Ophthalmology
|
July 28, 2022
Association Between Open Payments-Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
Andrew M Nguyen, Kelly E Anderson, Gerard Anderson, et al.
Journal of Pharmaceutical Policy and Practice
|
October 14, 2017
Branded prescription drug spending: a framework to evaluate policy options
Jeromie Ballreich, G Caleb Alexander, Mariana Socal, et al.
Page
of 8